Xenia Cabagnols
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms.
Journal: Oncogene
Published: December 11, 2019
TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.
Journal: DNA repair
Published: February 10, 2016
A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm.
Journal: The New England journal of medicine
Published: February 12, 2015
Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.
Journal: Haematologica
Published: February 10, 2015
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.
Journal: Leukemia
Published: September 13, 2014
Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapy.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 21, 2014
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients.
Journal: PloS one
Published: June 03, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026